Clinical trial

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer…

NCT00273494 · Rigshospitalet, Denmark, Other · Unknown status

Key facts

NCT number NCT00273494
Title Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2
Official title Scandinavian Neoadjuvant Phase III Study of Induction Chemotherapy Followed by Irradiation Alone or Surgery Plus Irradiation in NSCLC Stage IIIA/N2 (T1N2, T2N2, T3/N2).
Lead sponsor Rigshospitalet, Denmark, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Non-Small Cell Lung Cancer
Intervention type Procedure
Interventions Surgery
Enrollment 406
Start date Jan 1, 1998
Completion Jan 1, 2008
First posted Jan 9, 2006
Last update posted May 22, 2008
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies